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General Considerations  
 
Reactions performed under inert atmosphere were carried out in a glovebox or using 
standard Schlenk techniques under a nitrogen atmosphere. Solvents for air- and moisture- 
sensitive reactions were dried over sodium benzophenone ketyl, calcium hydride, or by 
the method of Grubbs.1 Deuterated solvents were purchased from Cambridge Isotope 
Laboratories and vacuum transferred from sodium benzophenone ketyl (C6D6), calcium 
hydride (CD2Cl2) or used as received (DMSO-d6). All solvents, once dried and degassed, 
were stored under inert atmosphere over 4 Å molecular sieves. Anhydrous N,N-
dimethylformamide (DMF) was purchased from Aldrich and stored over molecular 
sieves. 1H and 19F NMR spectra were recorded on a Varian 300 MHz instrument at room 
temperature, and 13C{1H} NMR spectra were recorded on a Varian INOVA-500 MHz 
spectrometer at room temperature. Shifts are reported relative to the residual solvent 
peak. For paramagnetic samples, the window was –100 to 100 ppm, the acquisition time 
was 300 ms, the relaxation delay was set to 0 s, and ≥ 320 scans were taken on samples 
≤5 mM in concentration to get good signal-to-noise. Robertson Microlit Laboratories, 
Ledgewood, NJ, performed elemental analyses. Electrospray Ionization Mass 
Spectrometry and high resolution MS were performed in the positive ion mode using an 
LCQ ion trap mass spectrometer (Thermo) at the California Institute of Technology Mass 
Spectra Facility. 
 2-[N,N-Bis(trimethylsilyloxy)]aminopropene was synthesized following a 
literature procedure.2 In our hands, slow addition of the reaction mixture into the cold 
NaHSO4 solution during work up was crucial in keeping the product from decomposing. 
N,N'-dimethylethylenediamine was distilled from KOH at atmospheric pressure, then 
distilled from Na0. LMn3(OAc)3,3 Mn(OTf)2•CH3CN,4 LutHOTf,5 and 




N,N'-dimethyl-N,N'-bis(propanone-oxime)-ethylenediamine (HON4OH): Following 
the work of Ioffe  et al.,7 2-[N,N-bis(trimethylsilyloxy)]aminopropene (75 wt% with 
pentane, 7.29 g, 23.42 mmol, 2.2 equiv) was added to an oven-dried 100 mL round 
bottom with a stirbar sealed with a septum under N2 by syringe and needle. N,N'-
dimethylethylenediamine (0.94 g, 10.6 mmol) was transferred to oven-dried 25 mL round 
bottom sealed with a septum under N2 by syringe and needle. Both compounds were 
diluted with dry dichloromethane (23 mL & 10.6 mL, respectively, 1 M each). The 
diamine solution was then cannula transferred to the bis(trimethylsilyloxy)]aminopropene 
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solution. Dichloromethane (3 mL) was used to rinse the 25 mL round bottom and 
cannula. The homogeneous yellow solution was stirred at room temperature for 8 hours, 
at which point the reaction mixture was poured into MeOH (ca. 250 mL). This yellow 
solution sat unstirred for 6 hours, at which point volatiles were removed in vacuo to give 
an orange oil. Trituration in hexane caused the oil to solidify, and after decanting the 
hexane, trituration in Et2O and decanting again, an orange powder produced. The orange 
powder was then triturated in CH3CN, giving an orange solution and white powder that 
was collected on a medium frit. The powder was rinsed with CH3CN until all color was 
lost from the powder, which was then dried in vacuo for 8 hours (1.7 g, 69.6%). To 
further dry, the powder was rinsed on a frit with dry CH3CN in the glovebox and any 
remaining CH3CN was removed in vacuo (1.6 g , 65.5%).1H NMR (300 MHz, DMSO-d6, 
25 °C): δ 10.47 (s, 2H, NOH), 2.90 (s, 4H, N–CH2–C=N) , 2.38 (s, 4H, N–CH2–), 2.07 (s, 
6H, H3C–N), 1.72 (s, 6H, H3C–C=NOH).  13C{1H} NMR (126 MHz, DMSO-d6, 25 °C): 
δ 154.66 (C=NOH), 61.95 (N–CH2–C=N), 55.11 (N–CH2), 42.60 (H3C–N), 12.57 (H3C–
C=NOH). HRMS (FAB+): calcd. for C10H23N4O2 [M+H]: 231.1821; found: 231.1826.  
 
LMnIV3CaO4(OAc)3•THF (1): Improving upon literature procedures,3, 8 LMn3(OAc)3 
(10.89 g, 8.6 mmol) and Ca(OTf)2 (3.05 g, 9.0 mmol, 1.05 equiv) were mixed as solids in 
a 2 L round bottom flask with a stir bar inside a glovebox. THF (ca. 830 mL) and DME 
(ca. 70 mL) were added and the solution was stirred for 15-20 minutes before well-
powdered KO2 (1.83 g, 25.7 mmol, 3 equiv) was added slowly over 5-10 minutes. THF 
(ca. 30 mL) and DME (ca. 16 mL) were added to rinse down any KO2 on the walls and to 
bring the final concentration to 9 mM and a ratio of 10:1 THF/DME. The round bottom 
was sealed with a 180º joint, taken out of the glovebox, and magnetically stirred. The 
solution changed colors from tan at 20 minutes, to brown at 45 minutes, grey-purple at 2 
hours, and dark brown at 20 hours. At four days, red, crystalline precipitate was 
observed, and by seven days the solution also had a reddish hue. On the eighth day, the 
pressure was reduced inside the flask to more safely bring it back into the glovebox, 
where the red crystalline precipitate was collected by filtration of the reaction mixture 
through a celite pad on a 150 mL fritted funnel. The solid was rinsed with 100-150 mL 
CH3CN (until no color is visible in the CH3CN). The remaining solid was scraped into a 
500 mL round bottom flask, residual CH3CN was removed in vacuo, and the solid was 
triturated in a mixture of THF (150 mL) and benzene (20 mL) for ca. 20 minutes. The 
resulting mixture was filtered through a pad of celite, giving a red solution and red solid, 
which was scraped back into the 500 mL flask and re-triturated in THF/C6H6 to extract 
more product. This process of trituration and filtration was repeated until little to no color 
was observed in the filtered solution (ca. 3 x 200 mL THF/C6H6). The remaining solid 
was triturated in DMF (ca. 80 mL) and filtered to give a red solution separate from the 
THF/C6H6 fraction. At this point three solutions exist: the THF/DME/CH3CN solution 
from filtration of the reaction mixture, the THF/C6H6 fraction, and the DMF fraction. All 
were taken out of the glovebox and volatiles were removed by vacuum distillation. The 
red residue from the THF/C6H6 fraction is pure 1 (2.3 g, 20% yield), while the red residue 
from the DMF fraction (0.7 g, 6%) may contain some potassium salts. The residue from 
the THF/DME/CH3CN fraction was brought back into the glovebox, triturated in CH3CN, 
and collected on a pad of celite. The solid was rinsed with CH3CN until no more color 
came through, and then proceeded with the THF/C6H6 trituration and filtration cycle 
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performed above. The red solution was concentrated in vacuo to give more red powder 1 
(1 g, 9%). The total yield was approximately 35%. Spectroscopic and electrochemical 
features match the literature,8 although herein we report the 1H NMR and UV-Vis 
spectroscopic features for the first time: 1H NMR (300 MHz, C6D6 with a drop of THF 
for solubility, 25 ºC): 21.4, 11.3, 10.0, 8.6, 5.9, 5.1, -16.9 ppm. UV-Vis (λmax (nm) [ε (M–
1 cm–1)]): 245 (8.0x104), 310 (2.2x104), 365 (1.1x104), 490 (2.0x103), 710 (3.5x102). 
 
LMnIII2MnIV2O4(OAc)3 (2) from LMnIV3CaO4(OAc)3•THF (1): Complex 1 (6.8 mg, 5 
µmol) was dissolved in DMF (ca. 1.5 mL) to give a red/brown, homogeneous solution. 
Separately dissolved Mn(OTf)2•CH3CN (2.0 mg, 5 µmol) in DMF (ca. 0.5 mL) to give a 
clear and colorless solution, which was then added to the solution of 1. The solution turns 
from red/brown to brown within 30 seconds of addition. The solution was allowed to stir 
ca. 30 minutes, then removed volatiles in vacuo. The resulting brown residue was 
extracted with benzene, which was filtered and concentrated to dryness to afford 2 (6.5 
mg, ca. 100%). Spectral features match those found in previous work.3, 8 
 
[LMnIV3GdO4(ON4O)(OAc)(DMF)]OTf (4): In the glove box, a solution of HON4OH 
(2.6 mg, 0.01 mmol, 1 equiv) and Et3N (0.02 mmole, 2 equiv) in THF (2 mL) was added 
to [LMn3GdO4(OAc)3](OTf) (3) (15.6 mg, 0.01 mmol) in THF (2 mL). The dark brown 
solution was stirred magnetically for 12 hours and the solution was concentrated in vacuo 
to afford a brown solid. Crystals were obtained from DMF/THF/diethyl ether to yield the 
product as dark-brown crystals (15 mg, 91%). The NMR spectra were obtained in CD2Cl2 
and then concentrated to dryness for elemental analysis. 1H NMR (CD2Cl2, 300 MHz, 
25ºC): δ 18.6, 11.7, 10.9, 10.3, 9.4, 9.0, 8.7, 6.8, 4.4, -17.4 ppm. 19F NMR (CD2Cl2, 282 
MHz, 25 ºC): δ -78.2 ppm. Anal. Calcd. For C76H75Cl6F3GdMn3N11O15S (4•3CH2Cl2): C, 
45.50; H, 3.77; N, 7.68. Found: C, 45.68; H, 3.44; N, 8.11. UV-Vis (λmax [ε (M–1 cm–1)]): 
246 (9.6x104), 310 (2.6x104), 550 (1.5x103), 710 (1.5x102) nm. 
 
LMnIV3CaO4(ON4O)(OAc) (5): In a N2 glovebox, an oven-dried Schlenk tube with 
stirbar was charged with 1 (301 mg, 0.22 mmol) and dry DMF (50 mL). HON4OH (53 
mg, 0.23 mmol, 1.05 equiv) was separately dissolved in dry DMF (5 mL) and the 
resulting clear and colorless solution was added to the red/brown and clear solution of 1. 
The Schlenk tube was sealed, brought out of the glovebox and heated to 80 ºC in an oil 
bath for 40 minutes during which precipitate appeared in the solution. The volatiles were 
removed in vacuo. Back inside the glovebox, the red/brown residue was suspended in dry 
CH3CN and volatiles were removed in vacuo again to remove any remaining DMF. After 
further trituration with CH3CN (15-20 mL), the solids were collected on Celite and rinsed 
with CH3CN until it ran colorless. The solids, along with some Celite from the filtration, 
were triturated in CH2Cl2 to extract the product and filtered through Celite. Any 
undissolved solid was re-triturated until the CH2Cl2 runs colorless (ca. 3 cycles or 10-30 
mL). Removed volatiles in vacuo to afford red/brown 3 as a powder (130 mg, 42%). 1H 
NMR (300 MHz, CD2Cl2, 25 ºC) 59.9, 22.6, 11.4, 10.8, 10.3, 8.6, 8.5, 8.1, 8.0, 7.0, 6.8, 
4.9, 4.7, -13.2 ppm. Anal. Calcd. for C75.5H78N10O12.5Mn3CaCl (5•1.5E2O•0.5CH2Cl2: C, 
57.91; H, 5.02; N, 8.95. Found: C, 57.73; H, 4.78; N, 8.69. *5 was triturated in Et2O and 
concentrated to dryness three times in an attempt to remove the CH2Cl2. UV-Vis (λmax 
(nm) [ε (M–1 cm–1)]): 240 (7.3x104), 315 (1.8x104), 500 (1.8x103), 705 (7.0x101).  
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[LMnIV3CaO3(OH)(ON4O)(OAc)]OTf (6): In the glovebox, to partially dissolved 3 
(30.4 mg, 0.022 mmol) in CH2Cl2 (ca. 9 mL) was added dropwise LutHOTf (5.8 mg, 
0.023 mmol, 1.05 equiv) as a clear and colorless solution in CH2Cl2 (ca. 2 mL). As the 
LutHOTf is added to the stirred solution of 3, the solution becomes red/brown and 
heterogenous to darker red/brown and homogeneous. The LutHOTf vial was rinsed three 
times to ensure the full equivalent was added (total reaction volume is ca. 13 mL). The 
solution was filtered after 3 hours and removed volatiles in vacuo. The resulting 
red/brown solid was extracted with hexane followed by Et2O to remove the resulting 
lutidine. The remaining material was extracted into C6H6, filtered through Celite, and 
concentrated to dryness to afford red/brown solid 6 (34 mg, ca. 100%). Crystals 
amenable to XRD analysis were grown from vapor diffusion of Et2O into a C6H6 solution 
of 6. 1H NMR (300 MHz, CD2Cl2, 25 ºC) 59.7, 51.3, 34.9, 22.5, 16.9, 11.3, 10.4, 10.0, 
8.8, 6.8, -4.4, -8.4, -13.2, -18.3 ppm . 19F NMR (282 MHz, CD2Cl2, 25 ºC): -76.5 ppm. 
UV-Vis (λmax [ε (M–1 cm–1)]): 307 (2.4x104) nm. Anal. Calcd. for 
C70H63CaF3Mn3N10O14S: C, 53.82; H, 4.06; N, 8.97. Found: C, 53.57; H, 4.31; N, 8.65. 
 
LMnIV3CaO4(ON4O)(OAc)•Ag(OTf) (7): In the glovebox, 5 (13.0 mg, 9 µmol) was 
partially dissolved in CH2Cl2 (ca. 12 mL). AgOTf (2.6 mg, 10 µmol, 1.1 equiv) was 
dissolved in CH3CN (ca. 0.3 mL) and diluted with CH2Cl2 (ca. 1 mL). The clear and 
colorless AgOTf solution to the red/brown and heterogeneous solution of 5 dropwise. 
Within 5 minutes, the reaction mixture was clear and orange. At 11 hours the mixture 
was concentrated in vacuo. 5 was visible by 1H NMR spectroscopy; therefore, excess 
AgOTf (1 mg, 4 µmol, ca. 0.4 equiv) was added as a solution in CH3CN/CH2Cl2 and the 
resulting mixture was stirred for 15 hours and concentrated in vacuo to afford 7 as a 
red/brown solid. Crystals amenable to XRD analysis were grown from vapor diffusion of 
Et2O into a CH2Cl2 solution of 7. Upon repeating the procedure, 1.5-2.0 equivalents of 
AgOTf were found to be necessary to push the reaction to completion. 1H NMR (300 
MHz, CD2Cl2, 25 ºC) 46.1, 29.5, 26.9, 20.3, 14.0, 13.3, 11.2, 8.8, 8.5, 7.9, 6.7, 5.9, 4.0, -
5.3, -9.1, -12.7 ppm. 19F NMR (282 MHz, CD2Cl2, 25 ºC): -76.5 ppm Anal. Calcd. for 
C72H64Ag2CaCl2F6Mn3N10O17S2 (7•AgOTf•CH2Cl2): C, 43.00; H, 3.21; N, 6.97. Found: 
C, 43.32; H, 3.05; N, 6.96. *The excess AgOTf necessary to push the reaction to 
completion precipitated alongside 7 upon vapor diffusion of Et2O into the CH2Cl2 
solution of 7 and was difficult to remove by washing, as polar solvents that would extract 
AgOTf decompose 7. These were therefore analyzed together, giving the extra equivalent 
of AgOTf in the analysis. 7 is known to crystallize with solvents in the lattice, so a 
CH2Cl2 molecule is also observed. UV-Vis (λmax [ε (M–1 cm–1)]): 240 (7.1x104), 310 
(2.0x104), 710 (1.5x102) nm. 
 
Reaction of LMnIV3CaO4(OAc)3•THF (1) with LutHOTf: In the glovebox, 1 (13.9 mg, 
0.01 mmol) was partially dissolved in CH2Cl2 (4 mL) to give a red/brown, heterogeneous 
mixture. A solution of LutHOTf (2.7 mg, 0.01 mmol, 1.05 equiv) in CH2Cl2 (1 ml) was 
added, and the LutHOTf vial was rinsed three times to ensure the full equivalent was 
added (total reaction volume is ca. 6 mL). The solution was stirred 6 hours, and did not 
homogenize like the reaction of 5 with LutHOTf. Volatiles were removed in vacuo, and 
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the residue was extracted with CH2Cl2, which contained LutHOTf (Figure S9, bottom), 
and then C6D6 with a drop of THF (Figure S9, top), which contained pure, unreacted 1. 
 
Reaction of LMnIV3CaO4(ON4O)(OAc) (5) with M(OTf)2 (M=Mn2+, Co2+): In the 
glovebox, 5 (14 mg, 0.01 mmol) was partially dissolved in CH2Cl2 (ca. 10 mL). M(OTf)2 
(0.013 mmol, 1.3 equiv) was dissolved in CH3CN (ca. 0.5 mL) and diluted with CH2Cl2 
(ca. 1 mL). The clear and colorless (M=Mn2+) or clear and pink (M=Co2+) solution was 
added dropwise to the red/brown and heterogeneous solution of 5. Within 10 minutes the 
reaction mixture is clear. ESI-MS samples were prepared by diluting a small aliquot of 








Figure S2. 13C{1H} NMR spectrum of HON4OH in DMSO-d6 at 25 ºC. 
 
 
Figure S3. 1H NMR spectrum of LMnIV3CaO4(OAc)3•THF (1) in C6D6 with a drop of 




Figure S4. 1H NMR spectrum of LMnIII2MnIV2O4(OAc)3 (2) as synthesized in the 
literature 3 (top), or from 1 and Mn(OTf)2 (bottom). Both are in C6D6 at 25 ºC. 
 
Figure S5. 1H NMR spectrum of [LMnIV3GdO4(ON4O)(OAc)(DMF)]OTf (4) in 




Figure S6. 1H NMR spectrum of LMnIV3CaO4(ON4O)(OAc) (5) in CD2Cl2 at 25 ºC. 
 
Figure S7. 1H NMR spectrum of [LMnIV3CaO3(OH)(ON4O)(OAc)]OTf (6) in CD2Cl2 
at 25 ºC. 
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Figure S8. 1H NMR spectrum of LMnIV3CaO4(ON4O)(OAc)Ag(OTf) (7) in CD2Cl2 at 
25 ºC. 
 
Figure S9. 1H NMR spectra of the CH2Cl2 fraction (bottom, with peaks of LutHOTf 
starred, CD2Cl2 at 25 ºC) and benzene fraction (top, C6D6 w/ drop of THF, 25 ºC) of the 
non-reaction of 1 and LutHOTf.  
The paramagnetic peaks of the top spectrum match those of pure 1 (Figure S3). 
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ESI Mass Spectra 
 
Figure S10. ESI-MS of an aliquot from the reaction of 5 with Mn(OTf)2. 
 
Figure S11. Fragmentation (ms/ms) mode ESI-MS on the m/z 1615 peak from the 
reaction of 5 with Mn(OTf)2. 
 
Figure S12. Fragmentation (ms/ms) mode ESI-MS on the m/z 1501 peak from the 
reaction of 5 with Mn(OTf)2. 
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Figure S13. ESI-MS of an aliquot from the reaction of 5 with Co(OTf)2. 
 
Figure S14. Fragmentation (ms/ms) mode ESI-MS on the m/z 1618 peak from the 
reaction of 5 with Co(OTf)2. 
 
Figure S15. Fragmentation (ms/ms) mode ESI-MS on the m/z 1505 peak from the 





Special Refinement Details 
 
Crystallographic data have been deposited at the Cambridge Crystallographic 
Database Centre, and copies can be obtained on request, free of charge, by quoting the 
publication citation and the deposition numbers 1018270 (4), 1018269 (6), and 1018268 
(7).	  
Refinement of F2 against ALL reflections. The weighted R-factor (wR) and 
goodness of fit (S) are based on F2, conventional R-factors (R) are based on F, with F set 
to zero for negative F2. The threshold expression of F2 > 2σ( F2) is used only for 
calculating R-factors(gt) etc. and is not relevant to the choice of reflections for 
refinement. R-factors based on F2 are statistically about twice as large as those based on 
F, and R-factors based on ALL data will be even larger. 
Low-temperature diffraction data (φ-and ω-scans) were collected on a Bruker 
Kappa diffractometer coupled to an Apex II CCD detector with graphite monochromated 
Mo Kα radiation (λ = 0.71073 Å). The structures were solved by direct methods using 
SHELXS9 and refined against F2 on all data by full-matrix least squares with SHELXL-
201410 using established refinement techniques.11 Unless otherwise noted, all non-
hydrogen atoms were refined anisotropically. All hydrogen atoms were included into the 
model at geometrically calculated positions and refined using a riding model. The 
isotropic displacement parameters of all hydrogen atoms were fixed to 1.2 times the U 
value of the atoms they are linked to (1.5 times for methyl groups).  Unless otherwise 
noted, all disordered atoms were refined with the help of similarity restraints on the 1,2- 
and 1,3-distances and displacement parameters as well as rigid bond restraints for 
anisotropic displacement parameters. The high angle data for all three compounds is 
weak which resulted in lower resolution data collected for compounds 6 and 7. 
 Compound 4 crystallizes in the triclinic space group P-1 with one molecule in the 
asymmetric unit along with a triflate anion, diethyl ether and water. The triflate anion was 
disordered over two positions. The occupancy of the two anions refined to 
0.508(8):0.495(8). The diethyl ether was also disordered over two positions. The 
occupancy of the two molecules refined to 0.635(11):0.365(11). The anisotropic 
displacement parameters for one of the diethyl ether molecules refined negative so the 
anisotropic displacement parameters for that molecule (O11S, C11S, C12S, C13S, C14S) 
were constrained to be equivalent. The hydrogen atoms for the water molecule could not 
be located in the difference Fourier synthesis and were not included in the model. 
Compound 6 crystallizes in the triclinic space group P-1 with one molecule in the 
asymmetric unit along with a triflate anion, benzene, diethyl ether and water. Two of the 
benzene molecules were modeled as two component disorders. The occupancy of these 
disordered molecules refined to 0.31(4):0.69(4) and 0.546(3):0.454(3), respectively. A 
second solvent accessible void was modeled as mixture of three mutually exclusive 
benzene molecules, one of which is located near a crystallographic inversion center and 
disordered accordingly. The occupancy of the three components refined to 
0.667(10):0.333(5):0.167(5). A third solvent accessible void is located near a 
crystallographic inversion center and modeled as a mixture of two diethyl ether and one 
benzene molecule. The occupancy of the three components refined to 
0.201(3):0.345(3):0.454(3). The anisotropic displacement parameters for one of the 
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diethyl ether molecules refined negative so the anisotropic displacement parameters for 
that molecule (O1W, C11W, C12W, C13W, C14W) were constrained to be equivalent. 
All benzene solvent molecules were restrained to be flat. The highest residual electron 
density maxima was modeled as a water molecule. The hydrogen atoms for the water 
molecule could not be located in the difference Fourier synthesis and were not included 
in the model. The anisotropic displacement parameters for one of the carbon atoms in the 
acetate (C71) became negative so C71 was refined isotropically for the final refinement. 
The resolution of this crystal is poor with diffracted intensity to at most 0.94 Å.  
Compound 7 crystallizes in the monoclinic space group I2/a with one molecule in 
the asymmetric unit along with 1.5 molecules of dicholoromethane and half a molecule of 
diethyl ether. All atoms were refined with the help of similarity restraints and enhanced 
rigid bond restraints for the anisotropic displacement parameters. The solvent molecules 
were refined with the help of similarity restraints on the 1,2- and 1,3-distances. There is 
an additional solvent accessible void that could not be modeled. The program 
SQUEEZE12 as implemented in Platon13 was used to remove the contribution of the 
disordered solvent to the structure factors.  
The data for 7 is poor with diffraction data to at most 1.15 Å.  In addition the 
diffraction reflections are smeared and the sample does not appear to be a single crystal. 
Although the quality of this structure is poor, it represents the best possible data obtained 
after multiple recrystallization attempts. Due to the poor quality of the data the identity of 
the silver atom is not certain, however, the chemical coordination, bond distances, and 
displacement parameters are consistent with silver over manganese or calcium. 
 
Table S1. Crystal and refinement data for complexes 4, 6, and 7. 
 4 6 7 
empirical 
formula C77H81F3GdMn3N11O17S C93.91H91.19CaF3Mn3N10O15.55S C74H71AgCaC3.5F3Mn3N10O14.5 
formula wt 1843.65 1902.55 1858.31 
T (K) 100(2) 100(2) 100(2) 
a, Å 14.8835(10) 13.9463(15) 31.574(4) 
b, Å 16.1532(11) 16.9456(18) 17.923(2) 
c, Å 16.7758(11) 21.456(2) 32.134(6) 
α, deg 88.985(3) 101.260(3) 90 
β, deg 89.785(3) 102.405(3) 119.365(3) 
γ, deg 69.483(3) 102.535(3) 90 
V, Å3 3776.7(4) 4676.2(8) 15849(4) 
Z 2 2 8 
cryst syst Triclinic Triclinic Monoclinic 
space group P-1 P-1 I2/A 
dcalcd, Mg/m3 1.621 1.351 1.558 
θ range, deg 1.461 to 26.442 1.553 to 22.212 1.349 to 17.999 
µ, mm-1 1.470 0.549 .996 





GOF 1.037 1.044 2.111 
R1,a wR2b (I 
> 2σ(I)) 0.1131, 0.1574 0.1404, 0.1878 0.2258, 0.4213 








 The desymmetrization of the electronic structure of 1 due to the coordination of 
[ON4O]2- was studied through the inspection of Pipek-Misek localized and delocalized 
(canonical) molecular orbitals. The following operations were executed using the 
computational package Jaguar 8.4.14 Ground-state optimizations for 1M, 5M, and 6M 
were accomplished via density functional theory (DFT) utilizing unrestricted B3LYP-d315 
with the lacv3p** basis on metals and 6-31G** on organics.16 The D3 modified B3LYP 
functional was employed to correct for dispersion forces.17 Before the subsequent 
solvation calculation, the trinucleating ligand framework was substituted with six 
protons: three spatially fixed protons in lieu of the rigid pyridine rings and three 
additional protons to correspond to the unrestrained pyridine rings. Bond analysis was 
similarly preformed on 5 in which a crystal structure was not obtained. Next, the 
delocalized and localized orbitals were obtained in tandem using the B3LYP-d3 
functional and larger basis set lacv3p**++ for metals Ca/Mn and 6-311G**++ for 
organics. The solvation calculation was accomplished in DMF solvent. The localized 
molecular orbitals were generated via the Pipek-Mezey orbital localization algorithm.18 
In particular, the sum of the orbital-dependent Mulliken charges is maximized in this 
approach. The HOMO and LUMO frontier orbitals were computed by visually inspection 
of the frontier orbital centered on the cubane core.  Orbitals located on organic ligand 
fragments were ignored.  Note that for 1M, the coordinated solvent molecule was 
selected as water instead of THF. 
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Figure S16. Bond coordinates of complexes 1, 5, and 6 from analysis of the DFT 
wavefunctions for the of truncated cubane model compared to structural parameters from 
the crystal structures. All reported values are measured in angstroms (Å). RMS values are 
calculated as 0.024 Å (1/1M) and 0.035 Å (6/6M), illustrating high geometric accuracy. 
Structure 5 was unable to be isolated as a crystal structure. 
 
Table S2. Mulliken populations of complexes 1, 5, 6. 
 
The Mulliken spin population analysis for complexes 1M, 5M, and 6M finds CaII and the 
three MnIV showing constant oxidation state during ligand exchange. No significant spin 
accumulates on the µ3-oxos within the cubane core for any of the geometries. 
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Figure S17. Pipek-Mizek Localized Orbitals and Delocalized HOMO/LUMO of 1M.  
Continued on next page. 
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Figure S18. Pipek-Mizek Localized Orbitals and Delocalized HOMO/LUMO of 5M. 
Continued on next page. 
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Figure S19. Pipek-Mizek Localized Orbitals and Delocalized HOMO/LUMO of 6M.  
Note that the triflate ligand coordinated to the µ3-hydroxo has been omitted for clarity. 
Continued on next page. 
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